Trials / Active Not Recruiting
Active Not RecruitingNCT06683508
A Study to Investigate Weight Management With LY3549492 Compared With Placebo in Adult Participants With Obesity or Overweight
A Phase 2, Parallel-Group, Double-Blind Study to Investigate Weight Management With LY3549492 Once Daily Compared With Placebo in Adult Participants With Obesity or Overweight
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 288 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to evaluate the effects of LY3549492 in adults with obesity or overweight. Participation in the study will last about one year.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LY3549492 | Administered orally |
| DRUG | Placebo | Administered orally |
Timeline
- Start date
- 2024-11-13
- Primary completion
- 2026-01-07
- Completion
- 2026-09-01
- First posted
- 2024-11-12
- Last updated
- 2026-03-20
Locations
49 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06683508. Inclusion in this directory is not an endorsement.